BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/13/2024 8:00:24 AM | Browse: 49 | Download: 237
 |
Received |
|
2024-05-01 10:19 |
|
Peer-Review Started |
|
2024-05-01 10:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-07-05 01:43 |
|
Revised |
|
2024-07-25 15:51 |
|
Second Decision |
|
2024-07-29 02:45 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-07-29 06:10 |
|
Articles in Press |
|
2024-07-29 06:10 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-08-01 09:09 |
|
Publish the Manuscript Online |
|
2024-08-13 08:00 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Dexamethasone and N-acetylcysteine before transarterial chemoembolization in hepatocellular carcinoma: A Western perspective
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Marco Biolato and Maurizio Pompili |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marco Biolato, MD, PhD, Staff Physician, Department of Medical and Surgical Sciences, CEMAD Digestive Disease Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo A. Gemelli 8, 00168, Rome 00168, Italy. marco.biolato@policlinicogemelli.it |
| Key Words |
Chemotherapeutic drugs; Lipiodol; Post-embolization syndrome; Prevention; Prophylaxis |
| Core Tip |
Post-embolization syndrome is the most common complication of transarterial chemoembolization, which represents the most widespread treatment of hepatocellular carcinoma. In a single-center, placebo-controlled trial, Simasingha et al documented the efficacy and safety of the prophylactic administration of dexamethasone and N-Acetylcysteine in the prevention of post-embolization syndrome in these patients. The applicability of this prophylaxis in the Western world presents some concerns. In the West, there are important differences in the disease etiology, the drug used, and the use of microspheres, compared to the Eastern scenario. Furthermore, the use of dexamethasone presents risks that must be carefully evaluated in this population. |
| Publish Date |
2024-08-13 08:00 |
| Citation |
<p>Biolato M, Pompili M. Dexamethasone and N-acetylcysteine before transarterial chemoembolization in hepatocellular carcinoma: A Western perspective. <i>World J Gastroenterol</i> 2024; 30(31): 3635-3639</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i31/3635.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i31.3635 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
